Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 532 of 5804
-
Can zapping just the growing spots keep cancer in check?
Disease control Recruiting nowTo find out if local consolidation therapy (such as radiation therapy with or without other local therapies such as surgery, ablation \[the removal or destruction of a body part or tissue or its function\], or embolization \[a procedure that uses particles, such as tiny gelatin s…
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug aims to boost immune cells in rare blood disorder
Disease control Recruiting nowThe purpose of this study is to demonstrate the efficacy and evaluate the safety and tolerability of mavorixafor in participants with congenital or acquired primary autoimmune and idiopathic chronic neutropenic disorders who are experiencing recurrent and/or serious infections as…
Phase: PHASE3 • Sponsor: X4 Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New combo therapy shows promise for tough esophageal cancer
Disease control Recruiting nowThis study was a single-center, single-arm, open-label phase II clinical trial. Thirty patients with unresectable locally advanced or postoperative recurrent esophageal squamous cell carcinoma were treated with concurrent chemoradiotherapy combined with immunotherapy. The radioth…
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New shot aims to silence hepatitis b virus for good
Disease control Recruiting nowA multicenter, randomized, open, parallel-designed Phase II study to evaluate the efficacy and safety of HRS-5635 injection alone or in combination with other agents in patients treated for chronic hepatitis B.
Phase: PHASE2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New combo therapy aims to boost melanoma treatment
Disease control Recruiting nowThis is a phase 3, randomized, controlled study of brenetafusp (IMC-F106C) plus nivolumab compared to standard nivolumab regimens in HLA-A\*02:01-positive participants with previously untreated advanced melanoma.
Phase: PHASE3 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New transplant approach aims to tame bone marrow failure
Disease control Recruiting nowA phase II trial of a reduced intensity conditioned (RIC) allogeneic hematopoietic cell transplant (HCT) with post-transplant cyclophosphamide (PTCy) for idiopathic severe aplastic anemia (SAA), paroxysmal nocturnal hemoglobinuria (PNH), acquired pure red cell aplasia (aPRCA), or…
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a common ED drug and cycling help kids with duchenne?
Disease control Recruiting nowExamining two strategies as potential adjuvant therapies for Duchenne muscular dystrophy (DMD); aerobic exercise training (to induce adaptations in skeletal muscle and improve cardiovascular health) and tadalafil, an FDA-approved vasodilator (to optimize blood flow and muscle per…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for breast cancer patients with brain tumors: targeted drug shows promise
Disease control OngoingTUXEDO-4 is an international, multicentric, single arm, phase II study aiming to gather additional solid evidence of Trastuzumab-Deruxtecan (T-DXd) activity in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-low breast cancer with active brain metastases. This stud…
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can sound waves calm both seizures and anxiety?
Symptom relief OngoingThe purpose of this study is to evaluate the feasibility, safety, and effects on anxiety of high intensity focused ultrasound ablation (FUSA) in patients suffering from treatment-refractory focal epilepsy and anxiety. FUSA is a non-invasive neurosurgical procedure that uses ultra…
Phase: PHASE1 • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
AI and PET scans could replace needle biopsies for prostate cancer grading
Diagnosis Recruiting nowProstate cancer is the most common type of cancer in Norwegian men, but many tumors are slow-growing and do not require treatment. Today, MRI is good at detecting suspicious lesions, yet it cannot reliably distinguish aggressive tumors from low-grade ones. As a result, many men u…
Sponsor: University Hospital of North Norway • Aim: Diagnosis
Last updated Jun 27, 2026 08:02 UTC
-
New pill combo aims to shrink Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis study is open to adults aged 18 years and older with different types of HER2+ cancer that has spread and cannot be removed by surgery. People can take part in this study if their tumours show HER2 aberrations and previous treatment was not successful. The purpose of this stu…
Phase: PHASE1, PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New weekly shot could help teens with obesity and related health problems
Disease control Recruiting nowThe goal of the study is to assess how tirzepatide impacts bodyweight and cardiovascular risk factors when used in conjunction with healthy nutrition and physical activity in adolescents with obesity and multiple weight related comorbidities. The study will last approximately 76 …
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New study aims to tackle perinatal depression with coordinated care
Symptom relief Recruiting nowThe collaborative care model (CCM) is a health services intervention that integrates mental health care in primary care settings. The goal of this study is to adapt the CCM to the perinatal care context, including community co-designed adaptations to enhance health equity (COMPAS…
Phase: NA • Sponsor: Women and Infants Hospital of Rhode Island • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
New TB detection methods could save thousands of lives in africa
Knowledge-focused Recruiting nowAs estimated by the WHO 10.6 million new Tuberculosis (TB) cases were identified in 2022- while more than three million went undetected and untreated. The low detection rate illustrates the failure to recognise and diagnose TB in the current cascade of healthcare and is a major o…
Phase: NA • Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Ketamine showdown: which form works best for stubborn depression?
Symptom relief Recruiting nowThe goal of this study is to compare the effectiveness of two formulations of ketamine - Spravato® and racemic ketamine - in people with treatment-resistant depression (TRD). The main questions it aims to answer are: * How the two formulations compare in terms of their effective…
Phase: PHASE4 • Sponsor: The George Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New trial aims to Fine-Tune prostate cancer treatment timing
Disease control Recruiting nowThis phase II trial studies the effects of stereotactic body radiation therapy (SBRT) and the timing of treatment with androgen receptor pathway inhibitor (ARPI) plus androgen deprivation therapy (ADT) in treating patients with hormone sensitive prostate cancer that has spread fr…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Eye drops could keep Kids' vision from getting worse
Disease control CompletedMyopia is one of the fastest-growing ocular disorders worldwide and has become a major public health concern, especially among children and adolescents. Progressive myopia is clinically significant because it increases the lifetime risk of serious ocular complications such as ret…
Phase: PHASE3 • Sponsor: Khyber Medical College, Peshawar • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Mind and body rehab program aims to boost quality of life in heart disease survivors
Disease control Recruiting nowRemarkable progress in paediatric cardiology and surgery have led to the substantial increase of congenital heart disease (CHD) survivors. Long-term outcomes in rare and complex CHD have become a critical priority as three major sources of morbidity have been identified in this p…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a structured course help people at suicide risk build a personal safety plan?
Prevention Recruiting nowThe plan is to include patients with a history of increased risk of suicide. In the aftermath of an episode of imminent suicide risk, patients will receive a psychoeducational course that entails information on different aspects of suicide-related topics, identifying triggers and…
Phase: NA • Sponsor: St. Olavs Hospital • Aim: Prevention
Last updated Jul 23, 2026 00:00 UTC
-
Hope for myelofibrosis patients: new drug combo aims to shrink spleens and ease symptoms
Disease control Recruiting nowThis clinical trial is evaluating whether addition of navtemadlin to ruxolitinib treatment will provide more clinical benefit than ruxolitinib alone for patients with Myelofibrosis who have a suboptimal response to ruxolitinib treatment alone. Subjects will start by receiving ru…
Phase: PHASE3 • Sponsor: Kartos Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC